In order to elucidate the role of guanine-nucleotide-binding proteins (G-proteins) To investigate the functional role of the diacylglycerol/protein kinase C arm of the phosphoinositide system, the cells were pretreated with the protein kinase C activator 12-O-tetradecanoylphorbol 13-acetate (TPA) or the protein kinase C inhibitor 1-(5-isoquinolinylsulphonyl)-2-methylpiperazine (H7). TPA inhibited the AlF4--induced inositol phosphate generation but stimulated both the release of arachidonic acid and the production of PGI2. H7 had opposite effects both on inositol phosphate generation and on PGI2 production. These results suggest that Al F4--induced PGI2 production is mediated by a pertussis-toxin-insensitive G-protein which activates the phosphoinositide second messenger system. This production of PGI2 can be modulated by protein kinase C activation, both at the level of inositol phosphate generation and at the level of arachidonic acid release.
INTRODUCTION
The phosphoinositide second messenger system has been shown to be a regulator of a variety of cell functions, including endothelial prostacyclin (prostaglandin 12; PGI2) production tl -3] . The binding of an agonist to a receptor on the cell surface activates phospholipase C which then splits phosphatidylinositol bisphosphate into the two second messengers, inositol trisphosphate and diacylglycerol. Inositol trisphophate releases Ca21 from intracellular stores, while diacylglycerol activates protein kinase C which phosphorylates several cell proteins [4, 5] .
In endothelial cells, agonist-stimulated PGI2 production has been shown to closely parallel inositol phosphate generation [1, 2] . PGI2 production has also been shown to be dependent on intracellular Ca21 stores [6] suggesting an important regulatory role for the inositol trisphosphate arm of the phosphoinositide system. Diacylglycerol is also formed after receptor activation in these cells [7] , but less is known about the role of this system in the production of PGI2. Pretreatment with phorbol ester, a protein kinase C activator, inhibits receptoractivated inositol phosphate generation and Ca2' release in endothelial cells [1, 8] , but the effect on the PGI2 production is more complex and depends both on the concentration of the agonist and on the duration of phorbol ester pretreatment [1] .
The existence of guanine-nucleotide-binding proteins (G-proteins), which couple receptors to their effector enzymes, is well established in the cyclic AMP system and in the activation by light of the retinal cyclic GMP phosphodiesterase. The G-proteins of those systems have been isolated and cloned [9] . Receptor coupling to phospholipase C has also been suggested to be a Gprotein-mediated process [10] . In several cell types, known G-protein activators have been shown to induce inositol phosphate generation [11] [12] [13] . Judging from the sensitivity to pertussis toxin, an inhibitor of Gi, the Gproteins involved in this activation seem to vary between different cell types [14, 15] . In endothelial cells pertussis toxin has been shown to inhibit ATP-induced inositol phosphate generation [16] , while having no effect on such generation in response to bradykinin [17] , suggesting involvement of different types of G-proteins. Recently, G-proteins have also been suggested to couple receptors directly to phopholipase A2, thus activating arachidonic acid release and prostaglandin production independently of phospholipase C activation, inositol phosphate generation and intracellular Ca2l release [18] [19] [20] [21] [22] .
The present study was After washing the cells twice with Hepes-buffered Earle's balanced salt solution (EBSS), the experiments were performed in 1 ml of this solution containing 20 mMLiCl. At the time points indicated in each experiment, the medium was removed for measurement of PGI2 and I ml of ice-cold trichloracetic acid (TCA) was added to quench cellular reactions. The inositol phosphates were separated as previously described [1] by applying the samples on columns of anion-exchange resin (AG-I x 8, 200-400 mesh, formate form) and quantified by liquid scintillation counting.
To permeabilize the cells we used the cell detergent digitonin (10 ,tg/ml) as described by Muldoon et al. [24] . The cells were washed in a cytosolic buffer, consisting of 120 mm-KCI, 10 mM-NaCl, 1 mM-KH2PO4, 5 mMNaHCO3, 10 mM-Hepes, buffered to 150 nM-Ca2+ with 0.2 mM-EGTA (calculated according to Thomas [25] ). The cells were then incubated in the same buffer containing 10 ,tg of digitonin/ml for 5 min. The buffer was then removed and the cytosolic buffer containing 100 ,#M-GTP with or without AlF4-(30 mM-NaF/10 ,UtMAlCl3) was added. At the times indicated, the buffer was removed and 10 % ice-cold TCA was added. The inositol phosphates, both in the buffer and in the cells, were then separated. Prostacyclin production PGI2 content was measured in the cell medium at the indicated times by radioimmunoassay for 6-oxo-prostaglandin F1<,, (6-oxo-PGF,,), a stable catabolite of PGI2, as described previously [1] . The antiserum used is highly specific showing 0.2400 cross-reactivity with PGE1 at 50 % displacement (bound/zero bound).
Arachidonic acid release
To measure the release of arachidonic acid, cells were incubated in medium 199 containing 20 Hepes-buffered EBSS, and then 2 ml of the same solution containing fatty-acid free bovine serum albumin (1 mg/ ml) was added. To minimize the interference from non-specific release of arachidonic acid that may follow any physical manipulation of cells, the stimulants were not added until 10-20 min later in small volumes of concentrated solutions to give the indicated final concentrations. At the time points indicated, 0.2 ml of the medium was removed and the concentrations of archidonic acid and its labelled metabolites in the sample were quantified by scintillation counting. When the cells were stimulated in low extracellular Ca2+, Hepes-buffered EBSS without Ca2`was used and EGTA (1.0 mM) and CaCl2 (0.30 mM) were added to give the final concentration of 60nm free Ca2+, calculated according to Thomas [25] . At the times indicated, CaCl2
(1.94 #smol) was added to give 5 intracellular Ca2" signal, we examined the intra-and extracellular Ca2" dependency of A1F4--induced arachidonic acid release. AIF4-induced a time-dependent release of arachidonic acid (Fig. 3) . The time curve is similar to the time curves for inositol phosphate accumulation and PGI2 production after AlF4-stimulation (Fig. 2b) . To determine the extracellular Ca2" dependency of this arachidonic acid release, the cells were stimulated with AIF4-in a solution containing approximately the resting levels of intracellular free Ca2" (50-100 nM) [6, 26] . As shown in Fig.   4 (a), AlF4-released arachidonic acid when in a medium with low extracellular Ca2", but this release came to a halt after about 20 min. When Ca2" was then added to the solution another burst of arachidonic acid release occurred. In order to deplete the intracellular Ca2" stores, the cells were pretreated with the Ca2" ionophore A23 187 (2 /XM) before AlF4-was added (Fig. 4b) [6] . This pretreatment totally inhibited the AlF4--induced arachidonic acid release when the cells were kept at the low extracellular Ca2" concentration. When Ca2" was then added to the solution, the arachidonic acid release rose rapidly. In Figs. 4(a) and 4(b), PGI2 accumulation is indicated below the corresponding curves, demonstrating that the rise in PGI2 production correlated well with the rise in arachidonic acid release. As shown in Table 1 , cells in low extracellular Ca2+ were still able to generate inositol phosphates in response to AIF4-after ionophore pretreatment.
Pertussis toxin pretreatment
In some cell systems, pertussis toxin discriminates between inositol phosphate formation and arachidonic acid release, suggesting the involvement of distinct Gproteins [21, 22] . In order to test this possibility in AIF4--stimulated endothelial cells, the cells were pretreated with pertussis toxin (500 ng/ml) for 14 h before stimulation. As shown in Table 2 , pertussis toxin affected neither inositol phosphate nor PGI2 production. In contrast, pretreatment with pertussis toxin inhibited the ATP-stimulated inositol phosphate production by approx. 60 (results not shown), as had previously been reported by Pirotton et al. [16] inositide system, we studied the effects of TPA, a protein kinase C activator and of the protein kinase C inhibitor H7 on the accumulation of inositol phosphates and the production of PGI2. TPA treatment for 5 min before adding AIF4-resulted in decreased accumulation of inositol phosphates (Fig.  5) . After 20 min of stimulation, the TPA-mediated inhibition was 470 and had reached 71 00 after 30 min of stimulation. Conversely, pretreatment with H7, a protein kinase C inhibitor, enhanced the generation of inositol phosphates after AlF4-stimulation by 280 (Table 3) .
For comparison, the effects of TPA and H7 on the production of PGI2 after AIF4-stimulation were examined. As shown in Fig. 6 , TPA markedly stimulated the production of PGI2. After TPA pretreatment, PGI2 production occurred at a lower concentration of A1F4- (Fig. 6a ) and also after a shorter time of stimulation (Fig.  6b) . TPA alone for 35 min did not induce PGI2 production (Fig. 6a) . Conversely, H7 reduced PGI2 production both after TPA pretreatment and also after AIF4-stimulation alone ( Table 4 ). The H7-induced inhibition was 290% after AlF4-stimulation alone and 38 00 when the cells had been pretreated with TPA. Finally, in order to further localize the effects of protein kinase C stimulation of PGI2 production, we examined the effect of TPA pretreatment on AlF4--induced arachidonic acid release. As shown in Fig. 7 , TPA both increased the amount of arachidonic acid released and reduced the time needed for the release to occur after stimulation by AIF4-. DISCUSSION This study shows that human umbilical vein endothelial cells exposed to the G-protein activator AIF4-respond by increasing the level of inositol phosphates, releasing arachidonic acid and producing PGI2. We also report on the involvement of Ca2l and protein kinase C in these processes and examine the effects of pertussis toxin pretreatment on the response of endothelial cells to AIF4-.
Although still not specifically identified, G-proteins have been widely suggested to couple receptors to phospholipase C [10] . These suggestions are based on experiments using the non-specific G-protein activators AlF4-[131 and non-hydrolysable GTP analogues [12, 13] and the more specific modulator of G-proteins, pertussis toxin. Sensitivity to cholera toxin and pertussis toxin has been used to distinguish between different types of Gproteins. Judging from pertussis toxin sensitivity, the type of G-protein involved in the activation of phospholipase C seems to vary between different cell types [14, 15] and even between different receptors on the same cell type [16, 17] . Of the two non-specific G-protein activator groups, AIF4-has the advantage over GTP analogues of not requiring permeabilization of the cells. This is important in our system because of the concurrent examination of arachidonic acid release and PGI2 production.
The effects of dose and time on inositol phosphate generation, arachidonic acid release and PGI2 production in response to AIF4-were very similar (Figs. 2 and 3) , suggesting a causal relationship. The slow accumulation of both the inositol phosphates and PGI2 compared with receptor agonists is most probably due to a different mechanism of activation. Whereas the receptor agonists have their effect on the receptor outside the cell, AIF4-has its effect on the G-proteins and must thus be taken up by the cell.
As shown in Fig. 2(b) , the total amount of inositol phosphates fell after 30 min despite the LiCl (20 mM) used to block degradation. This decrease is probably due to incomplete blocking by LiCl. The time response for 50 mM-NaF (Fig. 1 c) was shifted to the left compared with that for 30 mm (Fig. Ib) , with the total amount of inositol phosphates falling after 10 min of stimulation. Consequently, in the combined dose-response curves depicted in Fig. 2(a) representing 30 min of stimulation, there is a significant fall in total inositol phosphates at 50 mm. Since the PGI2 curve represents accumulation of a stable catabolite, no such fall would be expected. The similarity in the dose-and time-response curves for the inositol phosphate and PGI2 production after direct Gprotein activation by AF4-suggests a causal relationship and mimics the response to receptor activation of endothelial cells with the agonists bradykinin, thrombin and histamine [1] [2] [3] . These receptor agonists also increase the intracellular Ca2+ levels [2, 6, 26] , and Hallam et al. [6] have provided strong evidence that this increase in intracellular Ca2+ is a determining factor in PGI2 pro- Table 3 . Effects of H7 pretreatment on AIF4--induced inositol phosphate generation duction after thrombin activation. Their results argue quite strongly for a causal relationship between receptoragonist-stimulated inositol phosphate generation and PGI2 production in endothelial cells stimulated with thrombin. However, recently there have been indications that arachidonic acid might be released from cell membranes independently of inositol phosphate generation, possibly due to direct coupling of a receptor to phospholipase A2 by a G-protein [18] [19] [20] [21] [22] . In endothelial cells also there are some indications that arachidonic acid might be released independently of inositol phosphate generation. Pertussis toxin has been shown to inhibit inositol phosphate generation after ATP stimulation, while stimulating the production of PGI2 [16] . Leukotriene D4, which
'X Table 4 . Effects of H7 on AIF4--stimulated or AlF4--plus-TPA-stimulated PGI2 production Endothelial cells were. washed twice with or without H7 and then incubated in a buffer with or without H7
(100 tM) and/or TPA (100 ng/ml). After 10 min, buffer or AIF4-(30 mM-NaF/1O/M-AICI3) was added for 30 min.
Data are expressed as ng of 6-oxo-PGFL/ml measured by radioimmunoassay. Each value is the mean + S.E.M. of duplicate cultures from a representative of two experiments. induces PGI2 production in endothelial cells [27] , has been reported to activate phospholipase A2 without affecting the activity of phospholipase C in membrane preparations from endothelial cells [28] . In view of these results, the possibility has to be considered that AIF4--induced arachidonic acid release is not mediated by inositol phosphate generation but by a direct G-protein activation of phospholipase A2. Such activation could be either the result of a G-protein-coupled opening of a Ca2" channel, and thus be dependent on extracellular Ca"+, or a direct activation of phospholipase A2 independent of increased cytoplasmic Ca2l levels. In order to investigate these possibilities, we examined the intraand extracellular Ca2" dependency of the arachidonic acid release after A1F4-stimulation. When the cells were stimulated with AlF4-in a medium containing a low Ca2l concentration (60 nM), selected to approximate to resting intracellular Ca2" levels, the cells were still able to release arachidonic acid. The arachidonic acid release came to a halt after 20 min but another burst of arachidonic acid release was detected when Ca2" was added to the buffer (Fig. 4a) . The first phase of the thrombin-activated Ca2" rise has been reported to be independent of extracellular Ca2+ [29] . These results argue against the possibility that AlF4--stimulated arachidonic acid release is solely dependent on extracellular Ca2". To discriminate between arachidonic acid release mediated by a Ca2" signal from intracellular Ca2" stores and a direct activation of phospholipase A2, the cells were again maintained in the very low extracellular Ca2", but before AlF4-stimulation they were pretreated with the Ca2l ionophore A23 187 which has been shown to deplete releasable intracellular Ca2" stores in endothelial cells [6] . As shown in Fig. 4(b) , this pretreatment totally inhibited AlF4--induced arachidonic acid release. However, when
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Ca2" was added to the medium there was a rapid release of arachidonic acid. PGI2 production correlated well with the arachidonic acid release in these experiments (Figs. 4a and 4b) . The ionophore pretreatment in low extracellular Ca2+ did not inhibit the generation of inositol phosphates (Table 1) , excluding the possibility that this treatment was preventing the activation of phospholipase C. Emptying releasable intracellular Ca2+ stores thus inhibits AlF4--induced arachidonic acid release, suggesting that this release is dependent on intracellular Ca2+ stores and thus on activation of the phosphoinositide second messenger system. This conclusion is supported by the similar dose-and timeresponse curves for the increases in inositol phosphate accumulation, arachidonic acid release and PGI2 production. The lack of effect of pertussis toxin on the production of both inositol phosphates and PGI2 after AlF4-stimulation (Table 2) is also consistent with this conclusion.
We have previously shown that the protein kinase C activator TPA inhibits the generation of inositol phosphates after receptor activation with thrombin [1] . TPA also inhibits the receptor-activated Ca2' rise in endothelial cells [8] . This suggests that protein kinase C activation has a negative feedback role in endothelial cells, in accordance with the general feedback concept [4] . When AIF4--stimulated cells were pretreated with TPA, the generation of inositol phosphates was also markedly inhibited (Fig. 5) . Since AIF4-has its effect distal to the receptor in the cascade of signal transduction, these results suggest that TPA has its inhibitory effect at the level of a G-protein or possibly phospholipase C. Similar results have been obtained in fibroblasts [30] and hepatocytes [31] after AlF4 -stimulation. However, the TPA-activated protein kinase C arm has more than only a negative feedback role in cells. It has been shown both to induce arachidonic acid release by itself [32] and also to enhance arachidonic acid release in response to increased Ca2+ levels [33, 34] . Work in our laboratory has demonstrated that the effect of TPA pretreatment on PGI2 production in endothelial cells after thrombin activation was dependent on both the concentration of Vol. 264 thrombin and the duration of TPA pretreatment [1] . These results suggested a separate effect of protein kinase C on PGI2 production, independent of the effects on inositol phosphate generation. In the present study, pretreatment with TPA greatly amplified AlF4--induced PGI2 production, in contrast with the inhibition of inositol phosphate generation, although TPA by itself did not induce PGI2 production (Figs. 6a and 6b) . The effects of H7 on the endothelial cell response to AlF4-were opposite to the effects of TPA, with respect to both inositol phosphate generation and PGI2 production (Tables 3 and 4) . The results showing TPA-enhanced arachidonic acid release in response to AlF4; (Fig. 7) suggest that protein kinase C, when activated by TPA, stimulates PGI2 production by stimulating phospholipase A2 directly, or possibly through a regulatory protein. The demonstration that TPA inhibits inositol phosphate generation while potentiating PGI2 production might seem contrary to the proposition that the phosphoinositide second messenger system is the key regulator for the PGI2 production. But as the TPA-induced inhibition of inositol phosphate generation and Ca2+ release is only partial [1, 8] and as TPA also has a stimulatory effect on arachidonic acid release, the outcome is dependent on which effect (inhibitory or stimulatory) is dominant, and thus does not exclude a causal relationship between the two events.
Although TPA-activated protein kinase C thus seems to have a complex effect on the production of PGI2, there are reports that argue against a role for protein kinase C in this signal transduction pathway after agonist stimulation. Demolle et al. [35] have observed that the phosphorylation pattern after receptor agonist activation of endothelial cells has more resemblance to the pattern seen after Ca2+ ionophore treatment than the pattern observed after TPA treatment, suggesting that Ca2"/ calmodulin kinase rather than protein kinase C is activated. Hallam et al. [6] compared thrombin-and Ca21 ionophore-induced PGI2 production and suggested that the major (and probably exclusive) intracellular stimulus for the production of PGI2 in response to thrombin is the elevation of intracellular Ca2+. A similar suggestion was made after comparing ATP-and Ca2+ ionophore-stimulated PGI2 production [36] . Those findings thus suggest that the InsP3 arm of the phosphoinositide system in endothelial cells, resulting in an elevation in intracellular Ca2+ is the major mediator of signal transduiction, although diacylglycerol has been shown to be formed in these cells after agonist stimulation [7] . In contrast with these findings. Whatley et al. [37] have recently reported that protein kinase C has a stimulatory role in arachidonic acid release and platelet activating factor formation in endothelial cells, but only in the presence of a stimulus that increases intracellular Ca2+. These findings are consistent with our observation that TPA stimulates arachidonic acid release and PGI2 production only in the presence of AIF4-stimulation but not by itself.
In summary, we have demonstrated that stimulation of human umbilical vein endothelial cells with the nonspecific G-protein activator AF4-resulted in a rise of inositol phosphates, a release of arachidonic acid and the production of PGI2. This stimulation was pertussis toxininsensitive. The phosphoinositide second messenger system seems to be the main regulator of arachidonic acid release and thus PGI2 production since: (a) AIF4-could not release arachidonic acid in low extracellular Ca2l if intracellular Ca2l stores were depleted, suggesting that arachidonic acid release is dependent on intracellular Ca2l stores, and (b) there was close resemblance between the dose-and time-response curves for the three events; inositol phosphate generation, arachidonic acid release and PGI2 production. Finally, we report further evidence that protein kinase C may have a complex regulatory role in the production of PGI2, affecting inositol phosphate generation and the release of arachidonic acid in opposite directions.
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